Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulation by intravenous immunoglobulin.

P Imbach1, S Barandun, H Cottier

  • 1Central Laboratory, Blood Transfusion Service, Swiss Red Cross, Berne.

The American Journal of Pediatric Hematology/Oncology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain.

BMC anesthesiology·2021
Same author

Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel Disease.

Journal of Crohn's & colitis·2019
Same author

[Cost analysis of the use of botulinum toxin type A in Spain].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2014
Same author

Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.

Transplant infectious disease : an official journal of the Transplantation Society·2013
Same author

Quantitative renal cortical perfusion in human subjects with magnetic resonance imaging using iron-oxide nanoparticles: influence of T1 shortening.

Acta radiologica (Stockholm, Sweden : 1987)·2008
Same author

Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach.

Bone marrow transplantation·2003
Same journal

Transient abnormal myelopoiesis in Down's syndrome neonates.

The American journal of pediatric hematology/oncology·1994
Same journal

Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins.

The American journal of pediatric hematology/oncology·1994
Same journal

Maternal malignancy involving the products of conception: a report of malignant melanoma and medulloblastoma.

The American journal of pediatric hematology/oncology·1994
Same journal

Sphenoid sinus involvement in neuroblastoma.

The American journal of pediatric hematology/oncology·1994
Same journal

Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl.

The American journal of pediatric hematology/oncology·1994
Same journal

Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndrome.

The American journal of pediatric hematology/oncology·1994
See all related articles

Intravenous immunoglobulin-G (IVIG) rapidly increased platelet counts in children with idiopathic thrombocytopenic purpura (ITP). Further studies confirmed IVIG

Area of Science:

  • Immunology
  • Hematology
  • Pediatrics

Background:

  • Idiopathic thrombocytopenic purpura (ITP) is an immune-related disorder affecting platelet counts.
  • A serendipitous observation in 1980 noted a rapid platelet count increase in an ITP patient after receiving pooled human immunoglobulin-G (IVIG).

Purpose of the Study:

  • To investigate the efficacy of IVIG as a treatment for ITP.
  • To explore the potential immunomodulatory effects of IVIG.
  • To examine the broader applications of IVIG in immune-related disorders.

Main Methods:

  • A pilot study and two prospective multicenter studies were conducted.
  • The studies focused on pediatric patients diagnosed with ITP.
  • Clinical observations and platelet count monitoring were primary assessment methods.

Related Experiment Videos

Main Results:

  • The efficacy of IVIG in rapidly increasing platelet counts in children with ITP was confirmed.
  • Long-term observations suggested that IVIG can modulate immune responses.
  • These findings prompted further research into IVIG's mechanism of action and its use in other immune disorders.

Conclusions:

  • IVIG is an effective treatment for increasing platelet counts in pediatric ITP.
  • IVIG demonstrates potential immunomodulatory properties.
  • The therapeutic applications of IVIG extend to various immune-related conditions.